In DCM patients, abnormally elevated gal-3 levels were indicative of an increased MACEs risk (HR = 1.10, 95% CI [1.00–1.21], I2 = 65.7%, p = 0.008). The gene discussed is LGALS3; the disease is familial dilated cardiomyopathy.